SCHEMBL2323643

SCHEMBL2323643

O=[C]c1ccc(-c2cccnc2)o1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 9/20 0.57
CYP2C19 P33261 8/20 0.57
CYP2D6 P10635 7/20 0.57
CYP2C9 P11712 7/20 0.57
CYP2E1 P05181 6/20 0.57
CYP2B6 P20813 6/20 0.57
CYP2A6 P11509 15/20 0.55
ALDH1A1 P00352 3/20 0.47
CYP1A2 P05177 1/20 0.47
PIK3CA P42336 1/20 0.43
PIK3CG P48736 1/20 0.43
KDM4E B2RXH2 2/20 0.42
HPGD P15428 2/20 0.42
HSD17B10 Q99714 2/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
LMNA P02545 1/20 0.41
TP53 P04637 1/20 0.41
MAPT P10636 1/20 0.41
ALOX15 P16050 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2346044 0.77 ALDH1A1 (0.46) CYP3A4CYP2C19CYP2D6CYP2C9CYP2E1
SCHEMBL21249436 0.76 ALDH1A1 (0.62) CYP3A4CYP2C19CYP2D6CYP2C9CYP2E1
SCHEMBL2722995 0.73 ALDH1A1 (0.65) CYP3A4CYP2C19CYP2D6CYP2C9CYP2E1
SCHEMBL30387315 0.73 CYP2A6 (0.57) CYP3A4CYP2C19CYP2D6CYP2C9CYP2E1
SCHEMBL3601492 0.73 CYP2A6 (0.57) CYP3A4CYP2C19CYP2D6CYP2C9CYP2E1
SCHEMBL13680521 0.73 CYP2A6 (0.57) CYP3A4CYP2C19CYP2D6CYP2C9CYP2E1
SCHEMBL8587648 0.73 CYP3A4 (0.57) CYP3A4CYP2C19CYP2D6CYP2C9CYP2E1
SCHEMBL2323648 0.72 CYP3A4 (1.00) CYP3A4CYP2C19CYP2D6CYP2C9CYP2E1
SCHEMBL27605095 0.72 CYP2A6 (0.57) CYP3A4CYP2C19CYP2D6CYP2C9CYP2E1
SCHEMBL1651235 0.71 CYP2A6 (0.55) CYP3A4CYP2C19CYP2D6CYP2C9CYP2E1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011094890-A1 PHENYLALANINE DERIVATIVES AND THEIR USE AS NON-PEPTIDE GLP-1 RECEPTOR MODULATORS ARGUSINA INC. (US) 2011-08-11 WO disclosed